Program Goals. Gastric and Esophageal Cancer in the United States, 2013. Gastric Cancer Incidence: Geographic Differences. Gastric Adenocarcinoma: Heterogeneous Diseases. Gastric Cancer: Death Rates in the United States. Subcardial Gastric Cancer Incidence: Trends Among Different Age Groups.
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Gene Signature Validated in Primary Gastric Cancers: 2 Patient Cohorts
AVAGAST: Bevacizumab in First-line Gastric/GEJ Cancer - Phase 3 Trial
Neovascularization and VEGFR2 Expression from Barrett’s to Esophageal Adenocarcinoma
REGARD: Ramucirumab Monotherapy in Second-line Gastric/GEJ Cancer, Phase 3 Trial
RAINBOW: Ramucirumab in Second-line Gastric/GEJ Cancer, Phase 3 Trial